Binu Jacob

Binu Jacob

Auto-generated profile, based on publicly available information

Binu Jacob

Department of Bioscience and Biotechnology, Konkuk University, Seoul, 05029, South Korea

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 September 2013 in Journal of Peptide Science
Verified
Journal Article
Closed access
PDF file
BJBinu Jacob
Binu Jacob
IPIl‐Seon Park
Il‐Seon Park
JBJeong kyu Bang
Jeong kyu Bang
SSSong Yub Shin
Song Yub Shin

1 June 2012 in Peptides
Verified
Journal Article
Closed access
YNYong Hai Nan
Yong Hai Nan
JBJeong-Kyu Bang
Jeong-Kyu Bang
BJBinu Jacob
Binu Jacob
IPIl-Seon Park
Il-Seon Park
SSSong Yub Shin
Song Yub Shin

7 March 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JKJieun Kim
Jieun Kim
BJBinu Jacob
Binu Jacob
MJMihee Jang
Mihee Jang
CKChulhee Kwak
Chulhee Kwak
YLYeongjoon Lee
Yeongjoon Lee
YKYangmee Kim
Yangmee Kim
The development of novel peptide antibiotics with potent activity against multidrug-resistant Gram-negative bacteria and anti-septic activity is urgently needed. In this study, we designed short, 12-meric antimicrobial peptides by substituting amino acids from the N-terminal 12 residues of the papiliocin (Pap12-1) peptide to alter cationicity and amphipathicity and improve antibacterial activity and bacterial membrane interactions. Pap12-6, with an amphipathic α-helical structure and Trp12 at the C-terminus, showed broad-spectrum antibacterial activity, especially against multidrug-resistant Gram-negative bacteria. Dye leakage, membrane depolarization, and electron microscopy data proved that Pap12-6 kills bacteria by permeabilizing the bacterial membrane. Additionally, Pap12-6 significantly reduced the secretion of NO, TNF-α, and IL-6 and secreted alkaline phosphatase reporter gene activity confirmed that Pap12-6 shows anti-inflammatory activity via a TLR4-mediated NF-κB signaling pathway. In a mouse sepsis model, Pap12-6 significantly improved survival, reduced bacterial growth in organs, and reduced LPS and inflammatory cytokine levels in the serum and organs. Pap12-6 showed minimal cytotoxicity towards mammalian cells and controlled liver and kidney damage, proving its high bacterial selectivity. Our results suggest that Pap12-6 is a promising peptide antibiotic for the therapeutic treatment of Gram-negative sepsis via dual bactericidal and immunomodulatory effects on the host.

26 November 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RMRavichandran N. Murugan
Ravichandran N. Murugan
BJBinu Jacob
Binu Jacob
MAMija Ahn
Mija Ahn
EHEunha Hwang
Eunha Hwang
HSHoik Sohn
Hoik Sohn
JBJeong kyu Bang
Jeong kyu Bang
Much attention has been focused on the design and synthesis of potent, cationic antimicrobial peptides (AMPs) that possess both antimicrobial and anti-inflammatory activities. However, their development into therapeutic agents has been limited mainly due to their large size (12 to 50 residues in length) and poor protease stability. In an attempt to overcome the issues described above, a set of ultra-short, His-derived antimicrobial peptides (HDAMPs) has been developed for the first time. Through systematic tuning of pendant hydrophobic alkyl tails at the N(π)- and N(τ)-positions on His, and the positive charge of Arg, much higher prokaryotic selectivity was achieved, compared to human AMP LL-37. Additionally, the most potent HDAMPs showed promising dual antimicrobial and anti-inflammatory activities, as well as anti–methicillin-resistant Staphylococcus aureus (MRSA) activity and proteolytic resistance. Our results from transmission electron microscopy, membrane depolarization, confocal laser-scanning microscopy, and calcein-dye leakage experiments propose that HDAMP-1 kills microbial cells via dissipation of the membrane potential by forming pore/ion channels on bacterial cell membranes. The combination of the ultra-short size, high-prokaryotic selectivity, potent anti-MRSA activity, anti-inflammatory activity, and proteolytic resistance of the designed HDAMP-1, -3, -5, and -6 makes these molecules promising candidates for future antimicrobial therapeutics.

1 October 2013 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MAMija Ahn
Mija Ahn
RMRavichandran N. Murugan
Ravichandran N. Murugan
BJBinu Jacob
Binu Jacob
JHJae-Kyung Hyun
Jae-Kyung Hyun
CCChaejoon Cheong
Chaejoon Cheong
JBJeong Kyu Bang
Jeong Kyu Bang

1 August 2013 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
RMRavichandran N. Murugan
Ravichandran N. Murugan
BJBinu Jacob
Binu Jacob
EKEun-Hee Kim
Eun-Hee Kim
MAMija Ahn
Mija Ahn
HSHoik Sohn
Hoik Sohn
JBJeong Kyu Bang
Jeong Kyu Bang